Clinical Trial Update: Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial of vilazodone for major depressive disorder assessed efficacy, safety, and biomarkers of response; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vilazodone (vilazodone)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-10-27